CCR announces new educational feature

Written by...

The Clinical Cosmetic Regenerative Congress (CCR) 2026 will introduce The Injectable Experience, a new educational feature designed to give healthcare professionals practical insight into injectable products.

In a controlled hands-on setting, delegates will be able to handle syringes, explore rheology and discuss product characteristics with brand representatives and experienced practitioners. Companies will present product science, clinical use and practical considerations, while delegates gain a closer understanding of performance, handling and best practice in everyday clinical settings.

Brands including Ameela, Merz Aesthetics and Teoxane will showcase their standout injectable products currently making an impact in the medical aesthetics sector.

Other new features at this year’s event include the launch of the new Dentists in Aesthetic Practice Stage on Day 1 of CCR, reflecting the growing number of dental professionals entering or expanding within the medical aesthetics sector. Designed as a dedicated forum, the stage will provide discipline-specific education, expert insight and peer support for dentists already working in aesthetics, as well as those exploring opportunities in the field.

Shannon Kilgariff, event director and publisher at Aesthetics, commented, “The Injectable Experience has been created to give delegates a practical way to engage with injectable products, ask technical questions and better understand how different products perform in clinical settings, helping support more informed decision-making in everyday practice.”

Also new to the programme is the Hair, Scalp & Skin Stage on Day 2, which will shine a spotlight on one of the most rapidly evolving areas of medical aesthetics. The morning will feature independent educational content exploring the latest trends, clinical updates and developments in hair and skin health. The theme will then continue throughout the day with sponsored sessions dedicated to hair, scalp and skin.

Share this article: